American Healthcare REIT (AHR) EBITDA (2016 - 2026)
American Healthcare REIT filings provide 10 years of EBITDA readings, the most recent being $11.0 million for Q4 2025.
- On a quarterly basis, EBITDA rose 131.29% to $11.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was $71.3 million, a 278.96% increase, with the full-year FY2025 number at $71.2 million, up 287.94% from a year prior.
- EBITDA hit $11.0 million in Q4 2025 for American Healthcare REIT, down from $56.5 million in the prior quarter.
- In the past five years, EBITDA ranged from a high of $56.5 million in Q3 2025 to a low of -$48.9 million in Q4 2022.
- Median EBITDA over the past 5 years was -$7.3 million (2021), compared with a mean of -$8.2 million.
- Biggest five-year swings in EBITDA: plummeted 717.46% in 2023 and later soared 1578.37% in 2025.
- American Healthcare REIT's EBITDA stood at -$19.4 million in 2021, then plummeted by 152.04% to -$48.9 million in 2022, then surged by 48.13% to -$25.3 million in 2023, then crashed by 38.11% to -$35.0 million in 2024, then surged by 131.29% to $11.0 million in 2025.
- The last three reported values for EBITDA were $11.0 million (Q4 2025), $56.5 million (Q3 2025), and $10.4 million (Q2 2025) per Business Quant data.